For treatment of HCL, IFNα-2b given at a low dose of 2 million units/m2 subcutaneously three times a week for one year resulted in an overall response rate of 77% with a complete response rate of 5%, and this low dose was well-tolerated. Here, IFNA2 is linked to hairy cell leukemia.